Arndt Hartmann

Arndt Hartmann's AcademicInfluence.com Rankings

Arndt Hartmann

Physics

#4202

World Rank

#5815

Historical Rank

physics Degrees

Download Badge

Physics

Why Is Arndt Hartmann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Arndt Hartmann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Immune Landscape of Cancer (2018) (2766)
Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (2017) (1446)
Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (2018) (1224)
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours (2013) (1136)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. (2018) (1030)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer (2018) (574)
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 (2017) (561)
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma. (2016) (448)
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation (2005) (428)
Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) Are Common in Adults and Frequently Show c-KIT Mutations (2007) (364)
Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders (2011) (342)
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer (2003) (339)
Vascular occlusion by neutrophil extracellular traps in COVID-19 (2020) (307)
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer (2011) (306)
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment (2011) (299)
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. (2009) (288)
Multiple mutation analyses in single tumor cells with improved whole genome amplification. (1999) (258)
Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection (2012) (246)
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) (237)
Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity (2014) (235)
Molecular profiling of single circulating tumor cells with diagnostic intention (2014) (225)
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing (2010) (217)
Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. (2002) (209)
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. (2003) (206)
Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity. (2017) (204)
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. (2006) (201)
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern (2007) (194)
Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. (2014) (193)
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours (2009) (182)
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. (2012) (182)
Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. (1999) (182)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies (2002) (173)
Expression of fatty acid synthase in nonalcoholic fatty liver disease. (2010) (167)
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening (2012) (165)
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. (2008) (165)
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. (2004) (165)
Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract (2001) (164)
Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer (2006) (162)
Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11 (2014) (161)
Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. (2007) (157)
Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. (2014) (157)
Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. (2010) (157)
SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity (2017) (154)
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer (2004) (152)
Smoking and cancer‐related gene expression in bronchial epithelium and non‐small‐cell lung cancers (2006) (152)
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis (2008) (151)
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer (2008) (149)
Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (2016) (147)
The molecular epidemiology of p53 gene mutations in human breast cancer. (1997) (147)
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients (2008) (146)
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. (2014) (145)
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. (2010) (144)
SWI/SNF Complex–deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2 (2016) (143)
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer (2015) (140)
IL-9 and its receptor are predominantly involved in the pathogenesis of UC (2014) (139)
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma (2007) (138)
Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. (1996) (138)
Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses (2003) (136)
A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment. (2011) (133)
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. (2013) (133)
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer (2009) (131)
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis (2019) (131)
Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands (2019) (126)
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening (2013) (125)
Common breast cancer susceptibility loci are associated with triple-negative breast cancer. (2011) (124)
SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma (2014) (123)
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice (2013) (122)
Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study. (2012) (120)
Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. (2005) (118)
Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma (2011) (118)
Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival (2009) (117)
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment (2016) (117)
On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography (2013) (116)
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy (2005) (114)
Histopathologic Features and Microsatellite Instability of Cancers of the Papilla of Vater and Their Precursor Lesions (2009) (114)
Clonality and Genetic Divergence in Multifocal Low-Grade Superficial Urothelial Carcinoma as Determined by Chromosome 9 and p53 Deletion Analysis (2000) (114)
Warburg phenotype in renal cell carcinoma: High expression of glucose‐transporter 1 (GLUT‐1) correlates with low CD8+ T‐cell infiltration in the tumor (2011) (114)
Frequent microsatellite instability in sporadic tumors of the upper urinary tract. (2002) (113)
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients (2011) (111)
Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn’s disease (2018) (109)
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes (2019) (108)
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. (2019) (108)
Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. (2008) (107)
p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. (1995) (107)
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer (2008) (106)
SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. (2017) (106)
Distinction of Hereditary Nonpolyposis Colorectal Cancer and Sporadic Microsatellite-Unstable Colorectal Cancer through Quantification of MLH1 Methylation by Real-time PCR (2007) (106)
Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder (2005) (105)
PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis. (2016) (103)
Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC (2011) (101)
Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling (2008) (101)
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin (2013) (100)
Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage (2004) (100)
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer (2009) (100)
Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern (2016) (100)
Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. (2008) (100)
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer (2010) (99)
DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. (2009) (99)
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours (2008) (98)
A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps. (2007) (96)
Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder (2006) (96)
Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. (2015) (96)
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer (2017) (95)
Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer (2012) (93)
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer (2012) (93)
KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy (2011) (93)
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer (2021) (93)
S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer (2011) (93)
Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants (2010) (93)
Inflammatory biomarkers and bladder cancer prognosis: a systematic review. (2014) (92)
Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes (2010) (91)
SMARCB1 (INI1)-negative Rhabdoid Carcinomas of the Gastrointestinal Tract: Clinicopathologic and Molecular Study of a Highly Aggressive Variant With Literature Review (2014) (89)
Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients. (2009) (89)
Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker (2015) (89)
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer (2008) (89)
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer (2011) (87)
Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer (2005) (87)
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. (2007) (87)
Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors (2010) (85)
FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. (2007) (85)
High frequency of FGFR3 mutations in adenoid seborrheic keratoses. (2006) (84)
Cancer of unknown primary: clinicopathologic correlations (2003) (84)
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy (2013) (84)
Expression levels of the putative zinc transporter LIV‐1 are associated with a better outcome of breast cancer patients (2005) (83)
The plasmacytoid carcinoma of the bladder—rare variant of aggressive urothelial carcinoma (2011) (83)
Calcifying Fibrous Tumor of the Stomach: Clinicopathologic and Molecular Study of Seven Cases With Literature Review and Reappraisal of Histogenesis (2010) (83)
Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. (2014) (83)
Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity (2008) (82)
HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. (2003) (81)
Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients. (2016) (80)
Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. (2014) (80)
Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups (2018) (80)
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation (2008) (80)
Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. (2008) (80)
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. (2005) (80)
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer. (2020) (79)
Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases. (2008) (79)
Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study. (2017) (78)
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer (2008) (77)
Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing (2013) (76)
Increased expression of c-Jun in nonalcoholic fatty liver disease (2013) (76)
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial (2018) (75)
ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. (2008) (75)
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients (2008) (75)
Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes (2015) (74)
Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations. (2008) (73)
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer. (2012) (72)
Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade (2007) (72)
Identification of ZNF217, hnRNP‐K, VEGF‐A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma (2013) (71)
Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin‐embedded breast cancer (2005) (70)
Overexpression and mutations of p53 in metastatic malignant melanomas (1996) (70)
Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer (1994) (70)
Different types of microsatellite instability in ovarian carcinoma (2004) (69)
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer (2016) (69)
CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion (2018) (69)
Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance (2017) (68)
Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands (2019) (67)
SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotype (2017) (67)
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma (2007) (67)
Predicting individual outcomes after radical cystectomy: an external validation of current nomograms (2010) (67)
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. (2022) (66)
Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. (2006) (66)
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study (2014) (65)
Diabetes and prognosis in a breast cancer cohort (2011) (65)
Breast Cancer Risk - Genes, Environment and Clinics. (2011) (64)
Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer (2009) (64)
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. (2012) (64)
Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas (2017) (63)
A prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome (2000) (62)
DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions (2012) (62)
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissue (2011) (62)
Small‐interference RNA‐mediated knock‐down of aldehyde oxidase 1 in 3T3‐L1 cells impairs adipogenesis and adiponectin release (2008) (61)
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides. (2020) (61)
Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer—evaluation of a large hospital‐based single‐centre series (2011) (60)
FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization (2007) (60)
p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis. (1994) (60)
The proto‐oncogene ERG is a target of microRNA miR‐145 in prostate cancer (2013) (59)
PD-L1 assessment in urothelial carcinoma: a practical approach. (2019) (59)
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma (2009) (59)
Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy (2007) (58)
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. (2019) (58)
Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance. (2006) (57)
Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis. (2007) (57)
Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations. (2018) (57)
Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. (2010) (57)
Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. (2005) (57)
Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer (2011) (56)
Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum (2017) (56)
Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. (2003) (56)
Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer (2006) (55)
The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer (2015) (55)
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma (2015) (55)
MicroRNA profiles classify papillary renal cell carcinoma subtypes (2013) (54)
Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron. (2015) (54)
Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). (2011) (54)
KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ (2007) (54)
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial (2018) (53)
Nuclear Maspin expression is associated with response to adjuvant 5‐fluorouracil based chemotherapy in patients with stage III colon cancer (2006) (53)
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer (2009) (53)
Biofabrication of 3D Alginate-Based Hydrogel for Cancer Research: Comparison of Cell Spreading, Viability, and Adhesion Characteristics of Colorectal HCT116 Tumor Cells. (2016) (52)
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger (2007) (52)
Association of mammographic density with hormone receptors in invasive breast cancers: Results from a case‐only study (2012) (52)
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis (2015) (51)
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses. (2006) (51)
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy. (2013) (51)
Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation (2012) (50)
Lipomatous Salivary Gland Tumors: A Series of 31 Cases Spanning Their Morphologic Spectrum With Emphasis on Sialolipoma and Oncocytic Lipoadenoma (2013) (50)
Invasive Breast Cancer: Recognition of Molecular Subtypes (2011) (50)
The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression. (2010) (50)
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients (2018) (50)
Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure. (2009) (49)
Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma. (2006) (49)
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. (2019) (49)
Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non-Small Cell Lung Carcinoma. (2017) (49)
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018) (49)
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival (2017) (49)
Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus. (2009) (49)
Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature. (2020) (49)
FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo (2009) (48)
Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates? (2007) (48)
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer. (2005) (48)
Grating-based darkfield imaging of human breast tissue. (2013) (47)
Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency (2017) (47)
CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer (2019) (46)
No evidence for involvement of beta-catenin and APC in urothelial carcinomas. (2002) (46)
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†. (2020) (46)
Diagnostic Value of Immunohistochemical IMP3 Expression in Core Needle Biopsies of Pancreatic Ductal Adenocarcinoma (2011) (45)
Frequency of TERT Promoter Mutations in Prostate Cancer (2015) (45)
Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder. (2010) (45)
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells (2020) (45)
Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. (2007) (44)
Intermediate filament dynamics and breast cancer: Aberrant promoter methylation of the Synemin gene is associated with early tumor relapse (2010) (44)
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression. (2014) (44)
Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract (2016) (44)
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients (2018) (44)
Colonic Adenocarcinomas Harboring NTRK Fusion Genes (2019) (44)
Upper Tract Urothelial Carcinoma: A Clinicopathologic Study Including Microsatellite Instability Analysis (2002) (43)
New diagnostic criteria in real-time elastography for the assessment of breast lesions. (2010) (43)
Benign Serrated Colorectal Fibroblastic Polyps/Intramucosal Perineuriomas Are True Mixed Epithelial-stromal Polyps (Hybrid Hyperplastic Polyp/Mucosal Perineurioma) With Frequent BRAF Mutations (2010) (43)
Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer (2003) (43)
Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas. (2003) (43)
Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis. (2013) (42)
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell Carcinoma (2017) (42)
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data (2018) (42)
A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activity. (2014) (42)
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens (2016) (42)
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 (2020) (42)
VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis. (2015) (41)
RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid–induced protoporphyrin IX in vitro (2005) (41)
Laser Microdissection and Microsatellite Analyses of Breast Cancer Reveal a High Degree of Tumor Heterogeneity (2001) (41)
Plexiform angiomyxoid myofibroblastic tumour: differential diagnosis of gastrointestinal stromal tumour in the stomach (2008) (41)
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease (2014) (41)
Anthocyanins Prevent Colorectal Cancer Development in a Mouse Model (2017) (41)
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma (2016) (41)
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies (2014) (41)
pVHL/HIF-Regulated CD70 Expression Is Associated with Infiltration of CD27+ Lymphocytes and Increased Serum Levels of Soluble CD27 in Clear Cell Renal Cell Carcinoma (2015) (40)
Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions (2007) (40)
Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics (2014) (40)
Recurrent mutations within the amino-terminal region of β-catenin are probable key molecular driver events in sinonasal hemangiopericytoma. (2015) (40)
Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix (2018) (40)
Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma. (2010) (39)
Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. (2007) (39)
Neuropilin‐2 and its ligand VEGF‐C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients (2015) (39)
CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer. (2012) (39)
Insulin‐like growth factor II mRNA‐binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value (2012) (39)
Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening (2018) (39)
Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer (2015) (39)
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer (2008) (38)
Ultraviolet-excited (308 nm) autofluorescence for bladder cancer detection. (2002) (38)
Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. (2008) (38)
AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection (2015) (38)
Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer (2012) (38)
Optimal Lymph Node Harvest in Rectal Cancer (UICC Stages II and III) after Preoperative 5-FU–based Radiochemotherapy. Acetone Compression is a New and Highly Efficient Method (2012) (38)
FGFR3 Mutations in Benign Skin Tumors (2006) (38)
Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer (2006) (38)
Early aberrant insulin‐like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen (2008) (38)
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer (2016) (38)
mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants (2018) (38)
Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells (2019) (37)
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme (2019) (37)
Histologic-Genetic Mapping by Allele-Specific PCR Reveals Intraurothelial Spread of p53 Mutant Tumor Clones (2002) (37)
PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody (2011) (37)
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma (2014) (37)
Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis (2009) (37)
Hepatocellular Carcinoma in Southern Germany: Epidemiological and Clinicopathological Characteristics and Risk Factors (2002) (36)
NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas (2018) (36)
Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours. (2014) (36)
Examination of Apoptosis Signaling in Pancreatic Cancer by Computational Signal Transduction Analysis (2010) (36)
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma (2014) (36)
Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting. (1995) (36)
Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs (2009) (36)
Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer. (2012) (36)
Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer. (2006) (36)
Pancreatic panniculitis in a patient with pancreatic-type acinar cell carcinoma of the liver – case report and review of literature (2016) (36)
Phenotypical and molecular distinctness of sinonasal haemangiopericytoma compared to solitary fibrous tumour of the sinonasal tract (2014) (36)
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6 q 14 and 20 q 11 (2012) (36)
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study (2015) (36)
Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversity (2011) (36)
Low Frequency of Molecular Changes and Tumor Recurrence in Inverted Papillomas of the Urinary Tract (2007) (35)
HLA-E expression and its clinical relevance in human renal cell carcinoma (2016) (35)
The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis (2012) (35)
Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer. (2012) (35)
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes (2018) (35)
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis (2018) (35)
Hormone replacement therapy and prognosis in ovarian cancer patients (2013) (34)
Low frequency of epigenetic events in urothelial tumors in young patients. (2010) (34)
Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations (2013) (34)
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer (2011) (34)
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays (2019) (34)
Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. (2014) (34)
Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study (2018) (33)
Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. (2005) (33)
Unclassified renal cell carcinoma: a report of 56 cases (2012) (33)
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin. (2018) (33)
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper® (2017) (32)
Piwi-like 1 and 4 gene transcript levels are associated with clinicopathological parameters in renal cell carcinomas. (2014) (32)
Oligoclonality of Early Lesions of the Urothelium as Determined by Microdissection-Supported Genetic Analysis (2001) (32)
Familial and Sporadic Renal Oncocytomas – A Comparative Molecular–Genetic Analysis (2001) (32)
P53 Codon 72 (Arg72Pro) Polymorphism and Prostate Cancer Risk: Association between Disease Onset and Proline Genotype (2011) (32)
Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations—is the term “thyroblastoma” more appropriate? (2020) (32)
Insufficient Angiogenesis: Cause of Abnormally Thin Endometrium in Subfertile Patients? (2017) (32)
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater (2011) (32)
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy (2018) (32)
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation. (2010) (32)
Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes. (2007) (32)
Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing (2013) (31)
HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics (2014) (31)
Risk Factors for Endometriosis in a German Case-Control Study. (2011) (31)
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (2021) (31)
Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients (2017) (31)
Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations (2015) (31)
Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer (2014) (31)
DAPK1 loss triggers tumor invasion in colorectal tumor cells (2019) (31)
Nuclear E-cadherin Expression is Associated with the Loss of Membranous E-cadherin, Plasmacytoid Differentiation and Reduced Overall Survival in Urothelial Carcinoma of the Bladder (2013) (31)
Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma (2014) (30)
Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review (2007) (30)
Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy (2019) (30)
Non-professional phagocytosis: a general feature of normal tissue cells (2019) (30)
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes (2016) (30)
The Ras Effector RASSF2 Controls the PAR-4 Tumor Suppressor (2010) (30)
Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata) (2013) (30)
Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer (2006) (30)
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy (2020) (30)
Erratum: Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value (Proceedings of the National Academy of Science of the USA (February 6, 1996) 93 (1093-1096)) (1996) (30)
FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survival (2017) (30)
High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population. (1996) (29)
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. (2013) (29)
Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype. (2018) (29)
Biological predictors of radiosensitivity in head and neck squamous cell carcinoma (2017) (29)
Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas (2010) (29)
Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation (2007) (29)
Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation. (2003) (29)
Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long‐term analysis of 132 patients (2007) (29)
The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis (2019) (29)
Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer (2009) (29)
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non‐small cell lung cancer (2014) (29)
8p deletion is strongly linked to poor prognosis in breast cancer (2015) (29)
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer (2012) (29)
Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases (2018) (29)
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients. (2013) (28)
Small renal cell carcinomas--how dangerous are they really? Results of a large multicenter study. (2014) (28)
Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients. (2012) (28)
Sporadic segmental Interstitial cell of cajal hyperplasia (microscopic GIST) with unusual diffuse longitudinal growth replacing the muscularis propria: differential diagnosis to hereditary GIST syndromes. (2010) (28)
FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin. (2007) (28)
Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. (2016) (28)
Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review. (2012) (28)
FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. (2010) (28)
Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach. (2012) (27)
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019) (27)
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ (2016) (27)
Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options (2019) (27)
Characterization of lymphoid follicles with red ring signs as first manifestation of early Crohn's disease by conventional histopathology and confocal laser endomicroscopy. (2012) (27)
Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing. (2014) (27)
Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer (2019) (27)
Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients. (2004) (27)
Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity. (2013) (27)
Mismatch Repair Proteins hMLH1 and hMSH2 Are Differently Expressed in the Three Main Subtypes of Sporadic Renal Cell Carcinoma (2012) (27)
Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor (2015) (26)
Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy (2016) (26)
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials. (2021) (26)
No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer (2009) (26)
Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer (2016) (26)
Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populations. (1996) (26)
Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity (2016) (26)
Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility (2009) (26)
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making (2018) (26)
Heat Shock Protein 90-Sheltered Overexpression of Insulin-Like Growth Factor 1 Receptor Contributes to Malignancy of Thymic Epithelial Tumors (2011) (26)
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09) (2015) (26)
p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. (2007) (25)
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size (2014) (25)
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium (2020) (25)
The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo. (2009) (25)
TERT Core Promotor Mutations in Early-Onset Bladder Cancer (2016) (25)
Regulation of Uptake of 18F-FDG by a Follicular Human Thyroid Cancer Cell Line with Mutation-Activated K-Ras (2009) (25)
Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors. (2016) (25)
Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics (2008) (25)
Novel pattern of P53 mutation in breast cancers from Austrian women. (1995) (25)
PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception? (2016) (25)
Abstract S1-09: Evaluation of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarker in different subtypes of breast cancer treated with neoadjuvant therapy - A metaanalysis of 3771 patients (2017) (25)
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations. (2006) (24)
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis (2013) (24)
Genetic risk factors for ovarian cancer and their role for endometriosis risk. (2017) (24)
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis (2012) (24)
Piwil 2 Expression Is Correlated with Disease-Specific and Progression-Free Survival of Chemotherapy-Treated Bladder Cancer Patients (2015) (24)
Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters. (2009) (24)
Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. (2013) (24)
Benign mesenchymal tumours and tumour‐like lesions in end‐stage renal disease (2013) (24)
Diagnostic potential of major and trace elements in the serum of bladder cancer patients. (2018) (24)
ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC) (2016) (24)
Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential (2018) (23)
Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non‐muscle‐invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial (2020) (23)
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening (2018) (23)
Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells (2019) (23)
Prognostic impact of PD-1 and its ligands in renal cell carcinoma (2017) (23)
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (2019) (23)
Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases (2006) (23)
Expression and Localization of Lung Surfactant Proteins in Human Testis (2015) (23)
Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients. (2017) (23)
Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer (2020) (23)
Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases (2017) (23)
Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset? (2008) (23)
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review. (2010) (23)
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. (2019) (22)
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer (2018) (22)
Microsatellite Instability Predicts Poor Short-Term Survival in Patients with Advanced Breast Cancer after High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (2004) (22)
Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup (2016) (22)
Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys Mutation (2018) (22)
Immunohistochemical panel for the diagnosis of Hirschsprung's disease using antibodies to MAP2, calretinin, GLUT1 and S100 (2015) (22)
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis. (2021) (22)
Losses of 3p14 and 9p21 as shown by fluorescence in situ hybridization are early events in tumorigenesis of oral squamous cell carcinoma and already occur in simple keratosis (2008) (22)
BDNF Is Associated with SFRP1 Expression in Luminal and Basal-Like Breast Cancer Cell Lines and Primary Breast Cancer Tissues: A Novel Role in Tumor Suppression? (2014) (22)
Identification of DAPK as a scaffold protein for the LIMK/cofilin complex in TNF-induced apoptosis. (2013) (22)
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma (2019) (22)
Smooth and textured silicone surfaces of modified gel mammary prostheses cause a different impact on fibroproliferative properties of dermal fibroblasts. (2011) (22)
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. (2019) (22)
Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer. (2018) (22)
Prognostic and predictive value of estrogen receptor 1 expression in completely resected non‐small cell lung cancer (2013) (21)
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma (2020) (21)
Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium. (2005) (21)
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers (2005) (21)
Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder (2009) (21)
Select hyperactivating NLRP3 ligands enhance the TH1- and TH17-inducing potential of human type 2 conventional dendritic cells (2021) (20)
Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling (2021) (20)
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods (2017) (20)
Primary signet ring stromal tumor of the testis: a study of 13 cases indicating their phenotypic and genotypic analogy to pancreatic solid pseudopapillary neoplasm. (2017) (20)
DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base (2021) (20)
Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology. (2005) (20)
Neutrophil extracellular traps drive epithelial–mesenchymal transition of human colon cancer (2021) (20)
Intraoperative photodynamic evaluation of surgical margins during endoscopic extraperitoneal radical prostatectomy with the use of 5-aminolevulinic acid. (2009) (20)
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis (2017) (20)
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years (2017) (19)
Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer. (2014) (19)
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria (2018) (19)
Association of molecular subtypes with breast cancer risk factors: a case-only analysis (2014) (19)
Adult type granulosa cell tumor of the testis with a heterologous sarcomatous component: case report and review of the literature (2014) (19)
Long‐Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High‐Risk Bladder Cancer (Ta, Tis, T1, T2) (2019) (19)
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes (2017) (19)
B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction. (2013) (19)
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence (2015) (18)
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography (2016) (18)
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens (2012) (18)
First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival (2012) (18)
Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. (2002) (18)
Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer. (2017) (18)
Understanding PD-L1 Testing in Breast Cancer: A Practical Approach (2020) (18)
EGFR (HER) family protein expression and cytogenetics in 219 squamous cell carcinomas of the upper respiratory tract: ERBB2 overexpression independent prediction of poor prognosis. (2010) (18)
International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. (2021) (18)
Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer. (2013) (18)
Infiltrative lamina propria invasion pattern as an independent predictor for cancer‐specific and overall survival of instillation treatment‐naïve stage T1 high‐grade urothelial bladder cancer (2018) (18)
Cytokeratin-positive epithelioid angiosarcoma presenting in the tonsil: a diagnostic challenge. (2012) (18)
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage (2020) (18)
Hepatocyte Nuclear Factor (HNF) 4&agr; Expression Distinguishes Ampullary Cancer Subtypes and Prognosis After Resection (2011) (18)
Characterization of Molecular Subtypes of Paget Disease of the Breast Using Immunohistochemistry and In Situ Hybridization. (2018) (18)
Clinical Implications of the 2004 WHO Histological Classification on Non-Invasive Tumours of the Urinary Bladder (2006) (18)
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer (2017) (18)
Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation. (2020) (18)
Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. (2003) (18)
Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung (2014) (17)
Long term follow up of through-the-scope balloon dilation as compared to strictureplasty and bowel resection of intestinal strictures in crohn's disease. (2014) (17)
Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided. (2019) (17)
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma (2019) (17)
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients (2021) (17)
Sinonasal papillomas: A single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in "carcinoma ex papilloma". (2020) (17)
Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk. (2013) (17)
Risk factors associated with positive surgical margins’ location at radical cystectomy and their impact on bladder cancer survival (2021) (17)
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients (2014) (17)
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts (2019) (17)
Adenocarcinoma of the bladder following nephrogenic adenoma: a case report (2008) (17)
Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors (2021) (17)
Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater (2008) (17)
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients (2018) (17)
Perspectives, potentials and trends of ex vivo and in vivo optical molecular pathology (2018) (17)
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO‐04 randomized phase 3 rectal cancer trial (2019) (17)
Molecular cross-talk between Y5-receptor and neuropeptide Y drives liver cancer (2020) (17)
Designing and implementing a biobanking IT framework for multiple research scenarios. (2012) (17)
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma (2018) (17)
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians (2012) (16)
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS) (2018) (16)
Loss of Fumarate Hydratase and Aberrant Protein Succination Detected With S-(2-Succino)-Cysteine Staining to Identify Patients With Multiple Cutaneous and Uterine Leiomyomatosis and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome (2016) (16)
Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2 (2018) (16)
PD-L2: A prognostic marker in chromophobe renal cell carcinoma? (2017) (16)
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non‐muscle‐invasive bladder cancer (2018) (16)
Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease (2021) (16)
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study. (2015) (16)
SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases. (2015) (16)
Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer. (2016) (16)
FOXM1 predicts disease progression in non-muscle invasive bladder cancer (2018) (16)
Multi-colour FISH in oesophageal adenocarcinoma—predictors of prognosis independent of stage and grade (2014) (16)
Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer (2018) (16)
Gastrin mediated down regulation of ghrelin and its pathophysiological role in atrophic gastritis. (2013) (16)
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study (2014) (16)
Influence of insulin resistance on adiponectin receptor expression in breast cancer. (2009) (15)
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? (2022) (15)
Gene expression in Solitary Fibrous Tumors (SFTs) correlates with anatomical localization and NAB2-STAT6 gene fusion variants. (2021) (15)
Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19 (2022) (15)
WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach (2017) (15)
Expression of peroxisome proliferator activated receptor γ and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma (2006) (15)
Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype–genotype correlation (2016) (15)
Exploration of the APC/β-catenin (WNT) pathway and a histologic classification system for pulmonary artery intimal sarcoma. A study of 18 cases (2008) (15)
SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients. (2018) (15)
IFN-γ-driven intratumoral microenvironment exhibits superior prognostic effect compared with an IFN-α-driven microenvironment in patients with colon carcinoma. (2013) (15)
ApoA-I-binding protein (AI-BP) and its homologues hYjeF_N2 and hYjeF_N3 comprise the YjeF_N domain protein family in humans with a role in spermiogenesis and oogenesis. (2007) (15)
No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis (2019) (15)
No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract. (2004) (15)
Molecular-cytogenetic characterisation of sex cord-stromal tumours: CGH analysis in sertoli cell tumours of the testis (2007) (15)
Long noncoding RNA HOTAIR is upregulated in an aggressive subgroup of gastrointestinal stromal tumors (GIST) and mediates the establishment of gene‐specific DNA methylation patterns (2018) (15)
Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location. (2015) (15)
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer (2015) (15)
Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants (2019) (14)
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]. (2006) (14)
Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype (2020) (14)
RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes (2019) (14)
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial (2015) (14)
Signal Decomposition for X-ray Dark-Field Imaging (2014) (14)
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI (2019) (14)
Correlation of histological and macroscopic findings in peritoneal endometriosis. (2014) (14)
Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma (2019) (14)
Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients (2013) (14)
BAP1 Loss is a Useful Adjunct to Distinguish Malignant Mesothelioma Including the Adenomatoid-like Variant From Benign Adenomatoid Tumors (2020) (14)
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo (2019) (14)
Hitherto unknown additive growth effects of fluorene and 2-acetylaminofluorene on bile duct epithelium and hepatocytes in rats. (1991) (14)
Microsatellite Instability in Tumor and Nonneoplastic Colorectal Cells from Hereditary Non-Polyposis Colorectal Cancer and Sporadic High Microsatellite-Instable Tumor Patients (2001) (14)
Dedifferentiated and Undifferentiated Melanomas (2020) (13)
Clinical Course of Plasmacytoid Urothelial Carcinoma of the Upper Urinary Tract: A Case Report (2012) (13)
Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GIST. (2012) (13)
Easy performance of 6-color confocal immunofluorescence with 4-laser line microscopes. (2014) (13)
Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity. (2017) (13)
[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract]. (2006) (13)
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients (2021) (13)
[Specific types of bladder cancer]. (2016) (13)
The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients (2016) (13)
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer (2021) (13)
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial. (2016) (13)
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma (2018) (13)
[Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer]. (2005) (13)
Colorectal Adenocarcinomas Harboring ALK Fusion Genes (2020) (12)
The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer (2018) (12)
Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma (2015) (12)
Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays (2019) (12)
Identification of miRNA-mRNA Modules in Colorectal Cancer Using Rough Hypercuboid Based Supervised Clustering (2017) (12)
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients (2015) (12)
Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL (2018) (12)
SNAI1 Protein Expression is an Independent Negative Prognosticator in Muscle-Invasive Bladder Cancer (2013) (12)
Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes. (2013) (12)
Intraparotid Classical and Nodular Lymphocyte-predominant Hodgkin Lymphoma: Pattern Analysis With Emphasis on Associated Lymphadenoma-like Proliferations (2015) (12)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts (2016) (12)
A polymorphism but no mutations in the GADD45 gene in breast cancers (1996) (12)
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma. (2014) (12)
Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort (2021) (12)
DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells (2015) (12)
Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer (2015) (11)
Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases (2021) (11)
Mdm2 SNP309 G-Variant Is Associated with Invasive Growth of Human Urinary Bladder Cancer (2013) (11)
Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease. (2014) (11)
ypN0 nodal status after neoadjuvant chemoradiotherapy for rectal carcinoma is not associated with adverse prognosis as compared with pN0 after primary surgery (2014) (11)
Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater (2009) (11)
Is gender becoming relevant in uro-oncological research? A bibliographical analysis (2013) (11)
Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer (2020) (11)
Financing of certified centers: a willingness-to-pay analysis (2013) (11)
A Standard Mammography Unit – Standard 3D Ultrasound Probe Fusion Prototype: First Results Fusionsprototyp aus einem Standard-Mammografiegerät und einem Standard-3-D-Ultraschallkopf: erste Ergebnisse (2017) (11)
Serrated epithelial colorectal polyps (hyperplastic polyps, sessile serrated adenomas) with perineurial stroma: Clinicopathological and molecular analysis of a new series. (2018) (11)
Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T-cell infiltration. (2021) (10)
Gpr126 (Adgrg6) is expressed in cell types known to be exposed to mechanical stimuli (2019) (10)
Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa. (2014) (10)
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients (2013) (10)
Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial (2011) (10)
ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas (2021) (10)
Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations (2019) (10)
Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion (2021) (10)
Discrimination Analysis of Breast Calcifications using X-Ray Dark-Field Radiography. (2020) (10)
Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis (2020) (10)
Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. (2013) (10)
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment (2020) (10)
Functional analyses and prognostic significance of SFRP1 expression in bladder cancer (2015) (10)
Multicenter study validates PITX2 DNA methylation for risk prediction in tamoxifen-treated, node-negative breast cancer using paraffin-embedded tumor tissue (2005) (10)
Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma (2017) (10)
A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegib (2018) (10)
Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis (2017) (10)
HMGA2-WIF1 Rearrangements Characterize a Distinctive Subset of Salivary Pleomorphic Adenomas With Prominent Trabecular (Canalicular Adenoma-like) Morphology (2021) (10)
Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE) (2011) (10)
Hemochromatosis mutation in hepatitis C: histopathology. (1998) (10)
Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma. (2007) (10)
Low-grade Endometrioid Stromal Sarcoma of the Paratestis: A Novel Report With Molecular Confirmation of JAZF1/SUZ12 Translocation. (2018) (10)
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy (2020) (10)
A Metachronous, Atypical, Multifocal Renal Oncocytoma with a Concomitant Renal Cell Carcinoma of the Contralateral Side and Bilateral Multifocal Oncocytomas: Two Case Reports and Review of Literature (2005) (10)
Leydig cell tumors of the testis: a molecular-cytogenetic study based on a large series of patients. (2007) (10)
A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST). (2020) (10)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (2016) (10)
Lasermicrodissection--an important prerequisite for the molecular-genetic analysis of bladder cancer. (2003) (10)
Multi-Prototype Few-shot Learning in Histopathology (2021) (10)
Distinct secreted Frizzled receptor protein 1 staining pattern in patients with hyperplastic polyposis coli syndrome. (2004) (10)
Spontaneous rupture of a benign giant adrenal adenoma (2007) (10)
Tumour-Infiltrating Lymphocytes (TILs) and PD-L1 Expression Correlate with Lymph Node Metastasis, High-Grade Transformation and Shorter Metastasis-Free Survival in Patients with Acinic Cell Carcinoma (AciCC) of the Salivary Glands (2021) (10)
Histology of Luminal Breast Cancer (2020) (9)
Erratum to: DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions (2016) (9)
Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor? (2020) (9)
Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma. (2016) (9)
[Tularemia lymphadenitis. An emerging differential diagnosis of necrotizing granulomatous cervical lymphadenitis]. (2014) (9)
Normalized autofluorescence imaging diagnostics in upper GI tract: a new method to improve specificity in neoplasia detection. (2011) (9)
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma (2022) (9)
Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues (2020) (9)
Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study. (2014) (9)
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer (2021) (9)
Arginase expression impedes the resolution of intestinal inflammation by altering the fecal microbiome and the metabolome. (2020) (9)
Factors influencing breast changes after pregnancy (2013) (9)
MIB-1 and MCM-2 immunohistochemical analysis does not aid in identification of serrated colorectal polyps with abnormal proliferation. (2006) (9)
KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE) (2014) (9)
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer (2022) (9)
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor (2018) (9)
Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA (2014) (9)
Automatic Detection of Tumor Buds in Pan-Cytokeratin Stained Colorectal Cancer Sections by a Hybrid Image Analysis Approach (2019) (9)
Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients (2019) (9)
Orbital chondromyxoid fibroma. (2009) (9)
Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients (2015) (9)
Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology (2015) (9)
NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case (2021) (9)
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer (2019) (9)
Leiomyoma of the gallbladder: a case report with review of the literature and discussion of the differential diagnosis (2010) (9)
TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms (2020) (9)
Liver–Intestine-Cadherin Is a Sensitive Marker of Intestinal Differentiation During Barrett’s Carcinogenesis (2012) (9)
MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting (2021) (9)
Tumours of the renal pelvis and ureter (2004) (8)
Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib. (2010) (8)
[Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation]. (2008) (8)
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder (2018) (8)
Differenzialdiagnostik erblicher Dickdarmkarzinomsyndrome (2010) (8)
Combination of an ultrafast TWIST-VIBE Dixon sequence protocol and diffusion-weighted imaging into an accurate easily applicable classification tool for masses in breast MRI (2020) (8)
[Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer]. (2008) (8)
IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis. (2017) (8)
Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer (2019) (8)
c-Met in chromophobe renal cell carcinoma (2016) (8)
Seizure-induced neuronal apoptosis is related to dysregulation of the RNA-edited GluR2 subunit in the developing mouse brain (2020) (8)
BRAF mutations are alternative early molecular events in a subset of KIT / PDGFRA wild-type gastrointestinal stromal tumours (2009) (8)
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients (2021) (8)
Endometrial Dating Method Detects Individual Maturation Sequences During the Secretory Phase (2020) (8)
Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy (2020) (8)
Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probe (2018) (8)
Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria (2012) (8)
The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases (2013) (8)
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients (2019) (8)
Endogenous Retroviral–K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell Carcinoma (2021) (8)
[Differential diagnostics of hereditary colorectal cancer syndromes. The role of pathology]. (2010) (8)
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis (2022) (8)
Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix (2021) (8)
TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers (2021) (8)
Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma. (2014) (7)
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort (2021) (7)
Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer (2009) (7)
High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer (2020) (7)
miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma (2021) (7)
[Colorectal serrated adenoma: diagnostic criteria and clinical implications]. (2007) (7)
Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases (2021) (7)
Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading? (2017) (7)
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma. (2020) (7)
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin-fixed TUR biopsies. (2017) (7)
Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology. (2018) (7)
Expression of the LIM homeobox domain transcription factor ISL1 (Islet-1) is frequent in rhabdomyosarcoma but very limited in other soft tissue sarcoma types (2014) (7)
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients (2020) (7)
YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor (2020) (7)
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies (2017) (7)
1175PComparability of programmed death-ligand 1 (PD-L1) expression on tumor-infiltrating immune cells (IC) and tumor cells (TC) in advanced urothelial bladder cancer (UBC) using clinically relevant immunohistochemistry (IHC) assays (2017) (7)
Original article Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma (2012) (7)
Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas (2020) (7)
In vivo diagnosis and characterization of gastric Crohn’s disease using endomicroscopy and virtual chromoendoscopy (2012) (7)
2617 A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN) (2015) (6)
[Sinonasal tumors : News from the WHO with special reference to mesenchymal entities]. (2018) (6)
The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site‐dependent manner in gastrointestinal stromal tumours (2017) (6)
Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma (2014) (6)
Specific protein patterns characterize metastatic potential of advanced bladder cancer. (2010) (6)
Prominent entrapment of respiratory epithelium in primary and metastatic intrapulmonary non-epithelial neoplasms: a frequent morphological pattern closely mimicking adenofibroma and other biphasic pulmonary lesions (2020) (6)
[COVID-19 effects on the kidney]. (2021) (6)
Characterization of esophageal inflammation in patients with achalasia. A retrospective immunohistochemical study. (2019) (6)
Health Economic Evaluation of Different Decision Aids for the Individualised Treatment of Patients with Breast Cancer (2013) (6)
A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer (2019) (6)
[Future of mammography-based imaging]. (2014) (6)
Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease (2019) (6)
Mutational Activation of FGFR3 is Not Involved in the Development of Prostate Cancer (2010) (6)
Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis (2020) (6)
MSI testing (2021) (6)
Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma (2020) (6)
COVID-19 effects on the kidney (2021) (6)
Tumours of the urethra (2004) (6)
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer (2021) (6)
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy. (2007) (6)
Enhanced expression of BMP 6 inhibits hepatic fi brosis in non-alcoholic fatty liver disease (2015) (6)
Urothelial Bladder Cancer: An Update on Molecular Pathology with Clinical Implications (2017) (6)
Artificial Intelligence Technique for Gene Expression Profiling of Urinary Bladder Cancer (2006) (6)
18-Year-Old Woman with an Embryonal Rhabdomyosarcoma of the Uterus in Statu Nascendi. (2012) (6)
The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression (2022) (6)
Intra-abdominal EWSR1/FUS-CREM-rearranged malignant epithelioid neoplasms: two cases of an emerging aggressive entity with emphasis on misleading immunophenotype (2021) (6)
TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder (2020) (6)
Detection of Microcalcifications in Spiral Breast Computed Tomography with Photon-Counting Detector Is Feasible: A Specimen Study (2021) (5)
Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome. (2015) (5)
Transurethral en-bloc hydrodissection for non-muscle invasive bladder cancer: Results of a randomized controlled trial (2017) (5)
Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]. (2020) (5)
Evidence for diverse mutagens in breast cancer (1996) (5)
Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma (2012) (5)
Computer-Aided Diagnosis in Multiparametric MRI of the Prostate: An Open-Access Online Tool for Lesion Classification with High Accuracy (2020) (5)
MALDI Mass Spectrometry Imaging—Prognostic Pathways and Metabolites for Renal Cell Carcinomas (2022) (5)
Artificial intelligence and bladder cancer arrays. (2007) (5)
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)-mediated induction of the long noncoding RNA NICI. (2020) (5)
Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview (2021) (5)
HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions. (2014) (5)
Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma (2019) (5)
[Plasmacytoid and micropapillary urothelial carcinoma: rare forms of urothelial carcinoma]. (2011) (5)
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy (2021) (5)
Nivolumab As Salvage Therapy in Pediatric Patients with Relapsed and Refractory Lymphomas (2016) (5)
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians (2018) (5)
Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma (2015) (5)
Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients (2013) (5)
Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials. (2018) (5)
Pax‐5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome (2008) (5)
Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study. (2020) (5)
Mammographic density and prognosis in primary breast cancer patients (2021) (5)
Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (2021) (5)
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer (2022) (5)
Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment (2021) (5)
Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes (2021) (5)
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy. (2021) (5)
KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer (2021) (5)
Prognostic value of O‐6‐methylguanine‐DNA methyltransferase loss in salivary gland carcinomas (2013) (4)
Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup (2020) (4)
Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma (2016) (4)
Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer (2017) (4)
Hereditäre Nierenzellkarzinome (2010) (4)
Tissue microarray studies in bladder cancer (2008) (4)
IDKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells (2021) (4)
Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists (2021) (4)
Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process (2020) (4)
Abstract 5035: MicroRNA expression profiles classify renal cell carcinoma subtypes (2012) (4)
Second-line treatment of advanced urothelial cancer with paclitaxel and RAD001 (everolimus) in a German phase II trial (AUO trial AB 35/09). (2012) (4)
MP78-05 INVASION-ASSOCIATED MIRNAS S AS POSSIBLE DIAGNOSTIC BIOMARKERS OF MUSCLE INVASIVE BLADDER CANCER IN TUMOR TISSUES AND URINARY EXOSOMES (2018) (4)
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer. (2021) (4)
Multiphoton Microscopy Reveals DAPK1-Dependent Extracellular Matrix Remodeling in a Chorioallantoic Membrane (CAM) Model (2022) (4)
Helicobacter Infection and Gastric Adenoma (2021) (4)
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression. (2017) (4)
Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer (2021) (4)
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes (2021) (4)
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis (2019) (4)
Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol. (2018) (4)
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma (2021) (4)
Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment (2020) (4)
The synergism of spatial metabolomics and morphometry improves machine learning‐based renal tumour subtype classification (2022) (4)
Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84. (2012) (4)
Evaluation of a multi-colour fluorescence in situ hybridisation assay for the detection of bladder cancer-results from three European laboratories (2003) (4)
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]. (2018) (4)
Restoration of an academic historical gross pathology collection—refreshed impact on current medical teaching? (2018) (4)
Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition. (2022) (4)
Eosinophilic cystitis mimicking bladder cancer—considerations on the management based upon a case report and a review of the literature (2021) (4)
[Molecular changes in development and progression of urothelial carcinoma]. (2003) (4)
The outcome of patients with inflammatory bowel disease–associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer–a matched-pair analysis of survival (2021) (4)
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes (2022) (4)
Corrections to "Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression". (2017) (4)
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia) (2022) (4)
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer (2022) (4)
The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density (2022) (4)
[Hereditary colorectal cancer : An update on genetics and entities in terms of differential diagnosis]. (2017) (4)
Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma (2021) (4)
Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-up (2016) (4)
Massive steatosis hepatis: an unusual manifestation of Whipple's disease (2002) (4)
Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients (2016) (4)
DICER1 mutation-positive giant botryoid fibroepithelial polyp of the urinary bladder mimicking embryonal rhabdomyosarcoma. (2019) (4)
Hypoxia drives glucose transporter 3 expression through HIF-mediated induction of the long noncoding RNA NICI (2019) (3)
[Precancerous conditions in the urothelium. Early detection and molecular understanding through endoscopic fluorescence diagnosis]. (2003) (3)
[Head and neck neoplasms : News from the WHO classification of 2017]. (2018) (3)
ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2 (2022) (3)
[Hereditary renal tumors: More common than expected?]. (2016) (3)
Arrythmogenic Right Ventricular Dysplasia (2016) (3)
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients (2020) (3)
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making (2018) (3)
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior (2020) (3)
Correlation between referral cytology and in-house colposcopy-guided cytology for detecting early cervical neoplasia (2019) (3)
SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report (2021) (3)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
Microdissection for detecting genetic aberrations in early and advanced human urinary bladder cancer. (2005) (3)
Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment (2022) (3)
Comparison of CNN models on a multi-scanner database in colon cancer histology (2021) (3)
Digital pathology imaging and computer-aided diagnostics as a novel tool for standardization of evaluation of aganglionic megacolon (Hirschsprung disease) histopathology (2018) (3)
Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data. (2020) (3)
Robust Slide Cartography in Colon Cancer Histology - Evaluation on a Multi-scanner Database (2021) (3)
[Practical aspects of COVID-19 autopsies]. (2021) (3)
FGFR3 mutation analysis in flat urothelial hyperplasia - strong evidence for chromosome 9 deletions as the earliest genetic alterations in the development of papillary bladder cancer (2006) (3)
Lipomatous solitary fibrous tumors harbor rare NAB2-STAT6 fusion variants and show upregulation of the gene Peroxisome Proliferator Activated Receptor Gamma (PPARG) encoding for a regulator of adipocyte differentiation. (2021) (3)
[Plasmacytoid carcinoma. Five case reports of a rare variant of urothelial carcinoma]. (2008) (3)
Is laparoscopic extirpation of the cervical stump after laparoscopic supracervical hysterectomy justified in women with incidentally found atypical endometrial hyperplasia? (2011) (3)
Author Correction: Non-professional phagocytosis: a general feature of normal tissue cells (2020) (3)
Bladder Cancer Validation of the Diagnostic Value of NMP 22 W BladderChek W Test as a Marker for Bladder Cancer by Photodynamic Diagnosis (2006) (3)
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions (2021) (3)
The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors (2022) (3)
Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma. (2005) (3)
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection (2022) (3)
Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer (2021) (3)
Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases (2020) (3)
Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma (2005) (3)
Immunoscore as a parameter predicting time to recurrence and disease-free survival in T4N0 stage II colon cancer patients. (2020) (3)
PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer (2020) (3)
Flat intraurothelial lesions of the urinary bladder—do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice (2022) (3)
[Prognostic and predictive molecular markers for urologic cancers]. (2014) (3)
P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study (2018) (3)
[Skin tumors as marker lesions for tumor syndromes]. (2010) (3)
University of Birmingham Succinate dehydrogenase (SDH)-deficient renal carcinoma (2014) (2)
Combination of growth pattern and tumor regression identifies a high‐risk group in neoadjuvant treated rectal cancer patients (2017) (2)
[MSI testing : What is new? What should be considered? German version]. (2021) (2)
392 New pathological features predicting prognosis of early-invasive urothelial carcinoma: Quantitative substaging and tumour invasion pattern should assist WHO 1973 grading classification in predicting cancer-specific survival of stage pT1 bladder cancer (2016) (2)
Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy (2017) (2)
Significant differences in outcome between Immunoscore categories in stage I colon cancer patients. (2019) (2)
HLA-G-specific microRNAs a novel approach for targeting tumors (2013) (2)
The prognostic and predictive impact of genomic grade index (GGI) versus central grade or molecular class in intermediate-risk breast cancer (BC): Results from the EC-Doc trial. (2013) (2)
Abstract 2693: MDR1 and ERCC1 expression predict outcome in patients with locally advanced bladder cancer and adjuvant chemotherapy (2010) (2)
Laser microdissection for microsatellite analysis in colon and breast cancer. (2005) (2)
Molecular genetic analysis excludes implantation metastasis of basal cell carcinomas. (2003) (2)
Mucosal Mast Cell Distribution in the Gastrointestinal Tract of Children: A Preliminary Study for Establishing Reference Values (2021) (2)
Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's letter to the editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91. (2014) (2)
[Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance]. (2017) (2)
116 CYTOGENETIC GENOMIC HYBRIDISATION OF COLLECTING DUCT CARCINOMAS: DETERMINATION OF AN UNIQUE KIDNEY TUMOUR ENTITY. CLINICAL AND EXPERIMENTAL RESULTS OF THE GERMAN NETWORK RENAL CELL TUMOURS (2011) (2)
P1-06-03: Predictive Value of HER2, Topoisomerase-II (Topo-II) and Tissue Inhibitor of Metalloproteinases (TIMP-1) for Efficacy of Taxane-Based Chemotherapy in Intermediate Risk Breast Cancer – Results from the EC-Doc Trial. (2011) (2)
Abstract 3654: Prognostic role of androgen receptor in bladder cancer (2012) (2)
The HPV and p63 Status in Penile Cancer Are Linked with the Infiltration and Therapeutic Availability of Neutrophils (2020) (2)
Mitogenic short-term effects on hepatocytes and adrenocortical cells: phenobarbital and reserpine compared to carcinogenic and non-carcinogenic fluorene derivatives. (1998) (2)
Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium (2022) (2)
866 Second-line treatment of advanced urothelial cancer – safety of combinatory treatment with paclitaxel and RAD001 (everolimus) in a German phase II trial (AUO trial AB 35/09) (2012) (2)
[Clinical and immunohistochemical findings of intra- and extraoral angiosarcomas]. (2006) (2)
1174 CARCINOMA IN SITU (CIS) AND MUSCLE INVASIVE BLADDER CANCER ARE MORE COMMON IN WOMEN: THE ANALYSIS OF 600 PRIMARY CASES AT INITIAL PRESENTATION (2010) (2)
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting (2022) (2)
Endometrial delay is found to be part of a normal individual dynamic transformation process (2021) (2)
The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma (2022) (2)
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study (2014) (2)
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance (2022) (2)
Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer undergoing checkpoint inhibitor therapy. (2021) (2)
Abstract 1964: MicroRNA expression profiles classify renal cell carcinoma subtypes. (2013) (2)
Genomics Comparative microRNA Pro fi ling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing (2014) (2)
Abstract 3893: Endocan is upregulated on tumor vessels in invasive bladder cancer and mediates VEGF-A-induced angiogenesis. (2013) (2)
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer (2023) (2)
Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial) (2019) (2)
[What is new in the diagnosis and therapy of renal cell carcinoma?] (2020) (2)
The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response. (2022) (2)
Influence of expression of estrogen (ERS-1) and progesterone (PGR) receptors on metastatic spread and outcome in non-small cell lung cancer (NSCLC). (2011) (2)
Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands (2019) (2)
HFE gene mutations in patients with hepatocellular carcinoma (2000) (2)
Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments (2021) (2)
Undifferentiated and dedifferentiated urological carcinomas: lessons learned from the recent developments. (2021) (2)
[Primary mixed adeno-neuroendocrine carcinoma (MANEC) of the urinary bladder: a rare entity]. (2017) (2)
Praktische Aspekte von COVID-19-Obduktionen (2021) (2)
Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients (2021) (2)
Primary pseudomyogenic haemangioendothelioma of the testis with a novel POTEI::FOSB gene fusion (2022) (2)
A multicenter phase II trial of the combination cisplatin/ docetaxel/durvalumab/tremelimumab as single-cycle induction treatment in locally advanced HNSCC (CheckRad-CD8 trial). (2020) (2)
Analysis of Microsatellite Instability by Melting Peak Analysis with BAT26 and BAT25 Specific Fluorescence Hybridization Probes (2002) (2)
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study (2022) (2)
Downregulation of Checkpoint Protein Kinase 2 in the Urothelium of Healthy Male Tobacco Smokers (2016) (2)
Molecular Characterization of Muellerian Tumors of the Urinary Tract (2021) (2)
Abstract PD5-7: PTEN andPIK3CAbut not p4EBP1 are associated with low rates of pathological complete response (pCR) to trastuzumab based chemotherapy in primary HER2-overexpressing breast cancer (2015) (2)
Strong COX-2 overexpression in breast and prostate cancer - a potential therapeutic target. (2004) (2)
[c-MET Oncogene in Renal Cell Carcinomas]. (2016) (2)
[FISH analysis in the differential diagnosis of flat urothelial lesions using tissue microarrays]. (2004) (2)
Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study (2019) (2)
SWI/SNF Alterations in Squamous Bladder Cancers (2020) (2)
POSITIVE CYTOLOGY, BUT NEGATIVE WHITE LIGHT ENDOSCOPY: AN INDICATION FOR FLUORESCENCE CYSTOSCOPY IN BLADDER CANCER? (2006) (2)
Subclassification and outcome prediction of patients with muscle invasive urothelial carcinoma (MIUC) treated by radical cystectomy (RC) with a NanoString based molecular screening. (2016) (2)
946 CORRELATION OF GENOMIC ALTERATIONS AND HPV INFECTION IN PENILE CARCINOMA (2014) (1)
Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Quest (2021) (1)
Low Frequency of p53 Gene Mutations in Breast Cancers of Japanese-American Women (2001) (1)
Analysis of dendritic cells in human lymphoid organs (2012) (1)
Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma (2022) (1)
Signaling and Regulation Downregulation of Sec 23 A Protein by miRNA-375 in Prostate Carcinoma (2011) (1)
P53 gene mutations in breast cancers in Midwestern U.S. women: Null as well as missense-type mutations are associated with poor prognosis (1994) (1)
[Anamnesis, Pathological Assessment, Therapeutic Features and Course of Disease: Retrospective Study on Clinical-Based Factors for Prediction of Cancer-Specific Survival of 378 Patients with Stage pT1 Urothelial Bladder Carcinoma]. (2015) (1)
PV-0325: Tumor Regression Grading in the CAO/ARO/AIO-04 phase 3 trial in locally advanced rectal carcinoma (2017) (1)
Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer (2022) (1)
Epithelioid clear cell smooth muscle tumor of the ovary presenting as a mural nodule in an endometrioid adenocarcinoma with clear cell changes. (2011) (1)
Clinicopathological, immunohistochemical, molecular genetic, and ultrastructural study of two cases with literature review. (2007) (1)
Endocytoscopy for assessing histologic inflammation in ulcerative colitis: development and prospective validation of the ELECT score (ErLangen Endocytoscopy in ColiTis). (2022) (1)
Abstract 3700: Association of the G/G-SNP309 variant in the mdm2 gene with earlier tumor onset in female renal cell carcinoma patients (2016) (1)
Correlation of body mass index and menopausal status with the intratumoral estrogen system in invasive breast cancer (2008) (1)
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme (2020) (1)
Contents of Forthcoming Issues · Themenvorschau (2009) (1)
[Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]. (2021) (1)
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma (2022) (1)
Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells (2017) (1)
The Prognostic and Predictive Significance of Tumor-Infiltrating Memory T Cells Is Reversed in High-Risk HNSCC (2022) (1)
EGFR, PTEN, and survivin expression in pre- and posttherapeutic specimens does not predict a clinical benefit from preoperative chemoradiation with cetuximab in patients (pts) with locally advanced rectal cancer (LARC). (2010) (1)
[Role of predictive pathology in oncology--example of new therapies targeting EGFR]. (2006) (1)
Abstract P5-10-13: Low influence of tumor cell content on mRNA expression levels of ESR, PGR, HER2 and KI67 when performing the MammaTyper® RT-PCR kit (2015) (1)
Molecular differences between arterial and venous grafts in the first year after coronary artery bypass grafting (2020) (1)
326 INCIDENTAL AND CLINICALLY RELEVANT PROSTATE CANCER IS FOUND MORE FREQUENTLY IN THOROUGH VERSUS STANDARD HISTOPATHOLOGICAL PROCESSING IN RADICAL CYSTOPROSTATECTOMY SPECIMEN AND SHOULD BE CONSIDERED IN YOUNGER MEN (2010) (1)
Increased expression of OLFM4 and lysozyme during necrotizing enterocolitis in neonates: an observational research study (2022) (1)
Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second-line setting (2019) (1)
425 EMMPRIN (CD147): A POTENTIAL NEW TARGET PROTEIN IN THE TUMOUR PROGRESSION OF BLADDER CANCER (2009) (1)
Histopathologic and prognostic correlations regarding human papillomavirus (HPV) infection in penile squamous cell carcinomas (SCC) considering the novel 2016 WHO classification (2017) (1)
Artificial intelligence re-analysis of gene array data identifies novel markers of urothelial cancer progression (2007) (1)
F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial (2022) (1)
Successful Targeting of BRAF V600E Mutation With Vemurafenib in a Treatment-Resistant Extragonadal Nonseminomatous Germ-Cell Tumor. (2020) (1)
Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche (2022) (1)
Albinism with Hemorrhagic Diathesis and Pigmented Reticuloendothelial Cells (2009) (1)
Comparison of predictive and prognostic impact of molecular subtypes and central grade regarding taxane-based therapy in intermediate-risk breast cancer: Results from the EC-Doc trial. (2011) (1)
Fast whole-slide cartography in colon cancer histology using superpixels and CNN classification (2021) (1)
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study (2014) (1)
Persistent proliferation of normal hepatocytes and promotion of preneoplastic development byN-nitrosodibenzylamine in rats (2005) (1)
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer (2021) (1)
Risk assessment after neoadjuvant chemotherapy in luminal breast cancer: A prospectively planned validation of gene expression based and clinical prognostic scores in 428 residual tumor samples from two neoadjuvant clinical trials. (2016) (1)
Single-cell physical phenotyping of mechanically dissociated tissue biopsies for fast diagnostic assessment (2021) (1)
[Late Breaking Session Pathology and COVID-19 Report]. (2020) (1)
The role of Signal Transducer and Activator of Transcription protein 5 (STAT5) in non-small cell lung cancer (NSCLC) (2016) (1)
Sa1985 - Non-Invasive Evaluation of Disease Activity in Ulcerative Colitis using Multispectral Optoacoustic Tomography — a First-In-Human Diagnostic Clinical Trial (2018) (1)
Abstract P2-09-14: Evidence for Predictive and Prognostic Impact of Molecular Classification in Taxane-Based Chemotherapy in Intermediate Risk Breast Cancer — An Analysis of the WSG EC-Doc Trial: (2010) (1)
Further Evidence of Neuroprotective Effects of Recombinant Human Erythropoietin and Growth Hormone in Hypoxic Brain Injury in Neonatal Mice (2022) (1)
Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort (2022) (1)
[Hereditary head and neck tumors]. (2010) (1)
Prognostic impact of variant histologies in urothelial bladder cancer treated by radical cystectomy. (2023) (1)
Prognostic and Predictive Impact of Expression of the Angiogenic Markers CD105 and CD31 Expression in Patients with High Risk Breast Cancer (HRBC). (2009) (1)
BiasCorrector: Fast and accurate correction of all types of experimental biases in quantitative DNA methylation data derived by different technologies (2021) (1)
[Histopathology of renal cell carcinoma]. (2013) (1)
Circulating Serum Markers Correlate with Liver Fibrosis in Patients with Chronic Hepatitis C (2005) (1)
Prognostic impact of a 12-gene progression score in non-muscle invasive bladder cancer: A prospective multicenter validation study (2017) (1)
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients (2022) (1)
Su1879 Lymphocytic Esophagitis With or With No Apoptoses: Two Unequal Subgroups in the Wide Ranging Concept of Lymphocytic Esophagitis (2013) (1)
Gastrointestinal Pathology, Abstract 380–397, Study Group (2003) (1)
OC-0278: NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial (2018) (1)
Analysis of Intraoperative Frozen Pancreatic Resection Margin and Prediction of Postoperative Pancreatic Fistula Risk During Pancreatoduodenectomy. (2022) (1)
DMBT1 expression and neutrophil-to-lymphocyte ratio during necrotizing enterocolitis are influenced by impaired perfusion due to cardiac anomalies (2022) (1)
Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): Pooled analysis from the WSG AM-01 and -02 trials. (2011) (1)
BRAF mutation testing in melanoma: results from a German observational multicenter study (2018) (1)
779: Urothelial Neoplasms in Patients 20 Years or Younger: Rarity of Molecular Alterations and Favorable Clinical Outcomes (2006) (1)
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study (2022) (1)
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol. In press. (2020) (1)
Year : 2010 Cyclooxygenase 2 ( COX 2 ) and peroxisome proliferator-activated receptor gamma ( PPARG ) are stage-dependent prognostic markers of malignant melanoma (2010) (1)
GLUT1 and GLUT3 expression are increased in hepatocellular carcinoma and promote tumorigenesis (2009) (1)
Influence of insulin resistance on adiponectin receptor expression in breast cancer (2009) (1)
Prevention of fraud, corruption and bribery committed through legal entities for the purpose of financial and economic gain (2012) (1)
Abstract P3-06-36: Assessment of phosphorylated HER2 protein as predictive biomarker to stratify anti-HER2 treatment in HER2 non-amplified patients – A translational study in the GeparQuattro and GeparQuinto trials (2015) (1)
Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials. (2023) (1)
Idiopathic Mast Cell Activation Syndrome With Associated Salicylate Intolerance (2018) (1)
A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI – Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) (1)
A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022) (2022) (1)
The prognostic impact of Claudin 6 in papillary renal cell carcinoma. (2022) (1)
A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer (2021) (1)
Molecular analysis of inverted tumors of the urinary bladder (2005) (1)
[Calciphylaxis. A less well-known, clinically relevant disease]. (2011) (1)
Expression of nectin-4 in papillary renal cell carcinoma (2022) (1)
Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting (2020) (1)
[En-bloc resection of bladder tumours (ERBT): current and future perspectives]. (2017) (1)
Abstract 3656: Cathepsin E, Maspin, PLK1, and Survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer (2012) (1)
[Intraoperative frozen section diagnosis of the genitourinary tract]. (2012) (1)
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma. (2022) (1)
KRT5 and KRT20 expression predicts recurrence and progression of stage pT1 non-muscle-invasive bladder cancer (NMIBC) (2017) (1)
Superpixel Pre-Segmentation of HER2 Slides for Efficient Annotation (2022) (1)
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis (2012) (1)
[German Renal Cell Tumors Network]. (2007) (1)
Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis Mammakarzinomrisiko - Genetik und molekulare Mechanismen der Pathogenese (2013) (1)
Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trial. (2009) (1)
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium (2020) (1)
[Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple urothelial carcinomas with mutator phenotype]. (2005) (1)
Improved HER2 Tumor Segmentation with Subtype Balancing using Deep Generative Networks (2022) (1)
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients (2021) (1)
Assessment of the process of mucosal healing in ulcerative colitis upon anti-TNF therapy by using confocal laser endomicroscopy (2012) (1)
Concordance Rate of Colposcopy in Detecting Cervical Intraepithelial Lesions (2022) (1)
504 GLUT1 AND GLUT3 EXPRESSION ARE INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTE TUMORIGENICITY (2009) (0)
Economic Evaluation of Different Decision Aids for the Individualised Treatment of Patients with Breast Cancer (2013) (0)
AUTOCRINE WNT SIGNALING REGULATES CELL PROLIFERATION IN BLADDER CANCER (2009) (0)
Retraction Statement. Paper by Wang et al.: Oncology 2005;69:208-213 (DOI: 10.1159/000088332) (2015) (0)
98 The novel gene MIA2 promotes progression of hepatocellular carcinoma (2006) (0)
Abstract 3674: Protein levels of Piwi-like 1 and -2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients (2019) (0)
Abstract 2017: Exome sequencing reveals novel mutations in a GIST and a paraganglioma occurring simultaneously in a patient with complete form of Carney triad. (2013) (0)
43 VALUE OF CLINICAL AND HISTOPATHOLOGICAL PARAMETERS FOR PROGNOSIS OF PT1 UROTHELIAL BLADDER CANCER: A SINGLE-CENTER ANALYSIS OF 309 PATIENTS (2010) (0)
MP35-06 ESTABLISHMENT OF A FISH BASED ANALYSIS FOR INDIVIDUAL RISK ASSESSMENT OF CCRCC PATIENTS ON TISSUE MICRO ARRAYS (2015) (0)
Histopathological, clinical and molecular characterization of carcinomas of the upper urinary tract with mutator phenotype (2003) (0)
Identifying prognostic markers for high grade non-muscle invasive bladder cancer (2010) (0)
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma (2014) (0)
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma (2020) (0)
Abstract 4036: The microRNA profile of prostate carcinoma obtained by deep sequencing reveals potential miRNA targets such as myosin VI (2010) (0)
FGFR3 mutations in upper urinary tract tumors are independent from microsatellite instability and associated with favorable outcome and a lower rate of bladder cancer recurrence (2006) (0)
Microsatellite instability of tetranucleotide repeats (EMAST) in endometrial cancer (2004) (0)
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis (2023) (0)
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study (2023) (0)
381 IMPROVING GENE ARRAY ANALYSIS: THE APPLICATION OF ARTIFICIAL INTELLIGENCE IDENTIFIES NOVEL BIOMARKERS OF SUPERFICIAL BLADDER CANCER PROGRESSION (2007) (0)
SNPs ▼ and ▼ Disease ▼ Risk ▼ Modification ▼ in ▼ BCRA ▼ Mutation ▼ Carriers ▼ ▼ (2012) (0)
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041). (2023) (0)
Abstract PD11-03: PD11-03 Comparison of a mono Atezolizumab window followed by Atezolizumab and chemotherapy with Atezolizumab and chemotherapy in triple negative breast cancer – an interim analysis of the adaptive randomized neoadjuvant trial NeoMono (2023) (0)
The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer (2023) (0)
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and Subtyping (2022) (0)
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper® (2017) (0)
Abstract OT2-29-01: neoMono - An adaptive randomized neoadjuvant two arm trial in patients with TNBC comparing a mono atezolizumab window followed by atezolizumab and chemotherapy with atezolizumab and chemotherapy (2022) (0)
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2022) (0)
28P Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancer (2020) (0)
776 Establishment of a FISH based analysis for individual risk assessment of ccRCC patients on tissue micro arrays (2015) (0)
Touch imprint cytology and stereotactically-guided core needle biopsy of suspicious breast lesions: 15-year follow-up (2016) (0)
Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics. (2023) (0)
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018) (0)
Pancreatic panniculitis in a patient with pancreatic-type acinar cell carcinoma of the liver – case report and review of literature (2016) (0)
151 NATURAL TREATED HISTORY OF PATIENTS WITH UROTHELIAL CARCINOMA IN SITU (2007) (0)
558 Perinodal lymphovascular invasion displays the strongest predictor for cancer-specific mortality in lymph node positive patients with urothelial carcinoma of the bladder (2012) (0)
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria (2018) (0)
Contents, Supplement 2, 1993 (2004) (0)
Individual dynamics of uterine natural killer cells in natural and stimulated cycles monitored using a new endometrial dating method (2022) (0)
Nivoswitch trial: Predictive value of PD-L1 in plasma and extracellular vesicles. (2023) (0)
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. (2023) (0)
A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma (2023) (0)
Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma (2017) (0)
Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction; a retrospective analysis from experienced single center. (2021) (0)
[Accreditation in pathology and neuropathology in Germany : General regulations and requirements]. (2022) (0)
DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions (2012) (0)
Divergent immunobiological correlates of FDA-/EMA-approved PD-L1 assays and scoring algorithms in muscle-invasive bladder cancer (2020) (0)
Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients (2019) (0)
Robust Colon Tissue Cartography with Semi-Supervision (2022) (0)
A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study) (2022) (0)
Role of miRs in immune suppression (2014) (0)
Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder Tumors (2022) (0)
Abstract 6075: Comprehensive genomic characterization of early-stage bladder cancer from 438 patients by whole genome- and exome sequencing (2023) (0)
Diagnostic challenge of atypical colorectal metastasis to the renal pelvis. (2011) (0)
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis (2023) (0)
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer (2023) (0)
572 DECREASED EXPRESSION OF HYPOXIA-INDUCIBLE FACTOR 1A AND P27KIP1 IN PATIENTS WITH RENAL CELL CANCER (2010) (0)
Author Correction: Non-professional phagocytosis: a general feature of normal tissue cells (2020) (0)
Expression of OLFM4 and Lysozyme During Necrotizing Enterocolitis and Volvulus in Newborns: a Comparative Observational Research Study (2022) (0)
Abstract 3151: Molecular and clinicopathological impact of miR-375 deregulation in prostate cancer (2012) (0)
Analysis of dendritic cells in human lymphoid organs (2012) (0)
1 / BRAF mutation testing in melanoma: a study including Austria, Germany and UK, highlighting concordance for current technologies, and potential requirement of more sensitive technologies in future applications (2018) (0)
64 Promoter methylation and microsatellite mutation reveals the clonal relationship of multiple transitional cell carcinoma with the mutator phenotype (2005) (0)
Transrectal Absorber Guide Raster-Scanning Optoacoustic Mesoscopy for Label-Free In Vivo Assessment of Colitis. (2023) (0)
Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma. (2022) (0)
Spread through Air Spaces (STAS) in Solitary Pulmonary Metastases from Colorectal Cancer (CRC) (2022) (0)
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts. (2023) (0)
PD52-02 FGFR3 MUTATIONS AND THEIR RELATION TO FGFR3 EXPRESSION AND CLINICAL OUTCOME IN A LARGE RADICAL CYSTECTOMY COHORT: IMPLICATIONS FOR ANTI-FGFR3 BLADDER CANCER TREATMENT? (2019) (0)
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients (2018) (0)
Risk of penile tumor development in Caucasian individuals is independent of the coding variant rs7208422 in the TMC8 (EVER2) gene (2021) (0)
The role of Claudin-6 in chromophobe renal cell carcinoma. (2022) (0)
Rapid single-cell physical phenotyping of mechanically dissociated tissue biopsies. (2023) (0)
Factors influencing BRAFV600 mutation testing quality in melanoma: Results from a large, non-interventional, multicenter study in Germany. (2016) (0)
MP51-17 IS EVERY PT3A-PROSTATE CANCER (PCA) WITH POSITIVE SURGICAL MARGIN A CANDIDATE FOR ADJUVANT RADIATION (ARTX)? INDIVIDUAL RISK ASSESSMENT BASED ON A PATHOLOGICAL GLEASON SCORE PREDICTIVE MODEL – A MULTICENTRE STUDY (2014) (0)
Low Positivity for Hormone Receptors in Early Breast Cancer: Therapy-Response and Prognosis -A Systematic Analysis of a Total of 9027 Patients (2019) (0)
Immunohistochemical analysis of sex hormone receptors in squamous changes of the urothelium. (2022) (0)
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue (2022) (0)
919 Assessment of the Process of Mucosal Healing in Ulcerative Colitis Upon Anti-TNF Therapy (2012) (0)
University of Birmingham Magnification endoscopy with optical chromendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease (2019) (0)
WHO 2022 classification of penile and scrotal cancers: updates and evolution (2022) (0)
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells (2020) (0)
Anti-DNA-IgM Favors the Detection of NET-Associated Extracellular DNA (2023) (0)
Immunotherapy in Genitourinary Cancers: Role of Surgical Pathologist for Detection of Immunooncologic Predictive Factors (2022) (0)
Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naïve patients with non-small cell lung cancer (2022) (0)
Abstract 2259: Identifying causative genes and prognostic markers for bladder cancer (2011) (0)
WHAT DO THEY TEACH US ? (2018) (0)
Sa461 THE INFLAMMATORY BOWEL DISEASE – DISTRIBUTION, CHRONICITY, ACTIVITY (IBD-DCA) SCORE IS A NEW PROMISING INDEX FOR HISTOLOGIC ACTIVITY ASSESSMENT IN ULCERATIVE COLITIS AND CROHNS DISEASE (2021) (0)
Spatial immunophenotypes of distant metastases and response to immune checkpoint inhibition. (2023) (0)
Retrospective histological evaluation of orchiectomy specimens following testicular torsion reveals a 10% incidence of reversible injury. Is it time for a change of strategy? (2022) (0)
Abstract PR04: Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes (2020) (0)
Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients (2022) (0)
Uncertainty calibrated deep tissue classiﬁcation in histopathology (2022) (0)
892: Positve Cytology, but Negative White Light Endoscopy: An Indication for Fluorescence Cystoscopy in Bladder Cancer? (2006) (0)
Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes (2019) (0)
Definition of specific protein patterns in advanced bladder cancer for individual prognosis (2008) (0)
Strong COX-2-expression in hormone-refractory and metastatic prostate cancer — a potential therapeutic target (2004) (0)
Technical Advance Multiple Mutation Analyses in Single Tumor Cells with Improved Whole Genome Amplification (1998) (0)
Frequent loss of sFRP1 expression and sFRP1 promoter methylation in prostate cancer and adjacent histopathologically normal prostate. (2007) (0)
Abstract 780: Immune escape in colorectal carcinoma: role of the IFN-γ pathway (2011) (0)
P152: Long non-coding RNA HOTAIR affects DNA methylation patterns in gastrointestinal stromal tumours (GIST) (2015) (0)
[Organization of data and tissue banks for new prognostic factors in adenocarcinoma of the prostate. An interdisciplinary uropathologic approach]. (2007) (0)
785 Neuropilin-2 and VEGF-C are independent prognostic factors for bladder cancer patients treated with transurethral resection and radiochemotherapy (2014) (0)
MP46-17 THE IMPACT OF PATHOLOGICAL GLEASON SCORE ON BIOCHEMICAL RECURRENCE IN PATIENTS WITH PATHOLOGICALLY ORGAN-CONFINED T2 PROSTATE CANCER AND POSITIVE SURGICAL MARGINS: CAN WE JUSTIFY EXPECTANT MANAGEMENT OR IS ADJUVANT RADIATION THERAPY INDICATED? RESULTS OF A MULTICENTER EUROPEAN EVALUATION (2014) (0)
Barrett's syndrome? (1966) (0)
Validity of DNA-methylation marker PITX2 to predict risk of recurrence in lymph node-negative hormone receptor-positive breast cancer patients: a transfer study. (2005) (0)
Potential tumor targets for COX-2 inhibitor therapy — high throughput tissue microarray analysis of COX-2 expression (2004) (0)
Andersen disease (2019) (0)
Performance of FDA/EMA approved PD-L1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019) (0)
757 High ESR1 and PGR mRNA expression determined by RT-qPCR in FFPE routine tissue samples predicts superior disease specific survival in non-muscle invasive bladder cancer (2015) (0)
OP012 IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn’s disease patients (2018) (0)
[Definition of specific protein patterns for advanced (metastatic) urinary bladder tumors for individual prognosis determination and treatment choice]. (2007) (0)
Abstract 4327: Progranulin (GP88) is an independent prognostic factor for prostate cancer patients (2020) (0)
630 TFE3-TRANSLOCATION TUMOURS ARE MORE FREQUENT IN YOUNG ADULTS THAN IN OLD RENAL CELL CARCINOMA PATIENTS (2010) (0)
815 LOW FREQUENCY OF EPIGENETIC EVENTS IN UROTHELIAL TUMOURS FROM YOUNG PATIENTS (2010) (0)
Hereditäres Dickdarmkarzinom (2017) (0)
MP45-01 EXOSOMAL MIRNAS: KEY REGULATORS OF CELL-CELL COMMUNICATION BETWEEN BLADDER CANCER CELLS AND TUMOR MICROENVIRONMENT (2016) (0)
METRIC SUB‐STAGE ACCORDING TO MICRO AND EXTENSIVE LAMINA PROPRIA INVASION IMPROVES PROGNOSTICS IN T1 BLADDER CANCER: PD48‐05 (2017) (0)
Improving gene array analysis: The application of artificial intelligence identifies novel biomarkers of non invasive papillary bladder cancer progression (2007) (0)
Abstract 3937: Comparative genomic hybridization reveals complex genomic changes in plasmacytoid urothelial carcinoma (2015) (0)
248 Downregulation of CHEK2 protein kinase in the urothelium of healthy male tobacco smokers: One further step of urothelial carcinogenesis? (2014) (0)
The common functional C(−159)T polymorphism of the LPS receptor CD14 does not influence the disease outcome in patients with chronic hepatitis C infection (2002) (0)
Invasion-associated miRNA signatures as possible diagnostic biomarker of muscle invasive bladder cancer using tissue and urinary exosomes (2018) (0)
Abstract 2861: A novel negative regulation principle between DAPK and STAT3 in inflammation-associated carcinogenesis. (2013) (0)
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence (2020) (0)
Abstract 1482: MicroRNA expression profiles classify renal cell carcinoma subtypes (2014) (0)
Abstract 4779: TNF-induced Cofilin 1 phosphorylation by LIMK in colorectal tumor cells (2011) (0)
Abstract P2-10-06: Identifying patients sensitive to anthracycline-containing therapy with quantitative proteomic and genomic profiling (2018) (0)
Adenomatous Polyposis, Familial (2009) (0)
Abstract P4-12-07:CCND1amplification in early breast cancer patients: Correlation with subtypes and prognosis (2017) (0)
Promotor Methylation in Gastric Cancer – A Functional Trigger of Intestinal Differentiation Under Special Consideration of CDX1 Expression and NfκB Signalling (2011) (0)
Nuclear karyopherin alpha-2 (KPNA2) expression predicts poor survival in patients with advanced breast cancer. (2008) (0)
P4-02-07: Influence of the Progesterone Receptor on the Prognosis of Breast Cancer in Interaction with Other Prognostic Factors. (2011) (0)
Abstract 2224: EGFR mutation screening in non-small cell lung cancer: Results from 4 German molecular pathology laboratories (2011) (0)
1053 Infiltrative growth pattern, pT1 substaging and WHO grading 1973 are independent prognostic parameters of cancer-specific survival in early invasive urothelial bladder cancer: A single-center analysis of 335 patients (2015) (0)
MP30-05 DETECTION OF TRANSLOCATION TUMOURS ON RENAL CELL CARCINOMA TISSUE MICRO ARRAYS BY FISH (2014) (0)
824 PI3K/AKT/MTOR SIGNALING IN UROTHELIAL CARCINOMA AND ITS VALUE IN CANCER THERAPY (2010) (0)
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer (2012) (0)
354 Influence of the Progesterone Receptor On the Prognosis of Breast Cancer in Interaction with Other Prognostic Factors (2012) (0)
Aortic Root to Right Heart Shunts (2009) (0)
Prognostic impact of tumor infiltrating lymphocytes and immune cell related gene expression after radical cystectomy in muscle-invasive bladder cancer (2018) (0)
[Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder]. (2007) (0)
The role of STAT3 (signal transducer and activator of transcription 3) in non-small cell lung cancer (NSCLC) (2016) (0)
Risk assessment for ccRCC patients based on alterations in specific chromosomal regions (2017) (0)
MP28-06 PROMOTER HYPERMETHYLATION OF KISS1R, KISS1, SEPT9 AND CSAD AS A PROGNOSTIC BIOMARKER PANEL TO ASSESS THE METASTATIC POTENTIAL OF MUSCLE INVASIVE BLADDER TUMORS (2014) (0)
1030 COMPARATIVE GENOMIC HYBRIDIZATION (CGH) FINDINGS IN BELLINI DUCT CARCINOMAS (2009) (0)
PITX2 methylation and biochemical recurrence in postradical prostatectomy prostate cancer patients. (2009) (0)
Use of multidrug-resistance gene (MDR1) expression levels to predict outcome to adjuvant cisplatin/gemcitabine based chemotherapy in patients with with locally advanced urothelial cancer. (2009) (0)
Abstract 3825: High DAPK expression is correlated with worse prognosis in colorectal cancer patients (2014) (0)
Falk C. ThielAnton ScharlThomas HildebrandtEfstratios Kotziabassis • Michael G. SchrauderMayada R. BaniAndreas MullerTanja Hauzenberger • Christian R. LoehbergSebastian M. JudPeter A. FaschingArndt Hartmann • Rudiger Schulz-WendtlandVratislav StrnadMatthias W. BeckmannMichael Patrick Lux (2013) (0)
426 Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA (2015) (0)
Abstract P6-04-14: Integrating whole genome sequencing data with RNAseq, pathway analysis, and quantitative proteomics to determine prognosis after standard adjuvant treatment with trastuzumab and chemotherapy in primary breast cancer patients (2016) (0)
628 Micrornas Are Reproducibly Deregulated in Prostate Carcinoma and Are Potential Regulators of Signal Transduction Pathways Like Pi3-Kinase or Map-Kinase Pathways (2011) (0)
Abstract B23: FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment? (2020) (0)
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer (2012) (0)
Immunoscore feasibility study in routine postsurgical pathologic review for early-stage colon cancer (CC) cases risk-assessment. (2018) (0)
Expression of cyclooxygenase-2 (COX-2) and peroxisome proliferator-activated receptor gamma (PPARγ) in skin tumors (2007) (0)
Frequent microsatellite-instability of tetranucleotide repeats (EMAST) in ovarian cancer (2004) (0)
V45 INTRAOPERATIVE PHOTODYNAMIC EVALUATION OF SURGICAL MARGINS IN ENDOSCOPIC EXTRA PERITONEAL RADICAL PROSTATECTOMY WITH THE USE OF 5-AMINOLEVULINIC ACID (2010) (0)
43 Promoter hypermethylation of KISS1R, KiSS1, SEPT9 and CSAD as a prognostic biomarker panel to assess the metastatic potential of muscle invasive bladder tumors (2014) (0)
1407: Only Multiple and Larger Positive Surgical Margin Predict PSA-Recurrence After Radical Prostatectomy (2007) (0)
[Therapy selection in patients with advanced bladder cancer. Is molecular biology helpful?]. (2012) (0)
[In the service of uropathology. Students congratulate Prof. Dr. F. Hofstädter on his milestone birthday]. (2008) (0)
Ductal Carcinoma in Situ – Do We Really Need a New Nomenclature? (2009) (0)
Abstract 4823: Serum level of urokinase plasminogen activator receptor is suggested as diagnostic and prognostic biomarker in prostate cancer (2015) (0)
Molecular and Cellular Pathobiology 19 p 13 . 1 Is a Triple-Negative – Speci fi c Breast Cancer Susceptibility Locus (2012) (0)
371 “Natural treated history” in young adults with transitional cell carcinoma of the bladder (TCCB) (2004) (0)
Cytotoxic T cell related gene expression signature predicts improved outcome in muscle-invasive urothelial bladder cancer patients following radical cystectomy and adjuvant chemotherapy (2019) (0)
614: Microsatellite-Instability and Chromosomal Alterations in Urothelial Carcinoma of the Upper and Lower Urinary Tract: Evidence for Different Molecular Pathways (2005) (0)
419 Individual risk for biochemical recurrence in localized prostate cancer with positive surgical margins: A multicentre study (2014) (0)
Abstract 4642: Risk stratification of bladder cancer patients using a panel of 5 prognostic protein markers (2010) (0)
Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) (2019) (0)
1124 ENDOCAN IS UPREGULATED ON TUMOR VESSELS IN MUSCLE-INVASIVE BLADDER CANCER AND MEDIATES VEGF-A INDUCED ANGIOGENESIS (2013) (0)
Abstract 3090: miR-24 influences proliferation of prostate cancer cells in vitro via targeting ZNF217. (2013) (0)
Evaluation of different diagnostic methods for identification of FGFR alteration in advanced urothelial carcinomas: Proficiency results based on multiple RNA extraction kits and mutation detection methods (2019) (0)
O-17 A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study (2020) (0)
Association of KRT20 and KRT5 with response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer. (2020) (0)
P06.10: Fetal therapy in the first trimester (2006) (0)
Abstract 4009: Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep-sequencing (2015) (0)
The role of VEGF/mTOR/AKT pathway in patients with advanced urothelial carcinoma of the bladder cancer. (2013) (0)
PROGNOSTIC VALUE OF THE WHO 1973 AND 2004 CLASSIFICATION SYSTEMS FOR GRADE IN NON‐MUSCLE‐INVASIVE T1 BLADDER CANCER: PD57‐04 (2017) (0)
Early onset bladder cancers show distinct clinical, pathological and molecular features (2004) (0)
A prospective, open label, multicenter, randomized phase II trial: Sequential therapy with bevacizumab, RAd001 (everolimus) and axitinib in metastatic renal cell carcinoma (mRCC) (BERAT study). (2019) (0)
Link between BMP expression and clinical outcome in breast carcinomas (2009) (0)
The patterns of p53 gene mutations differ inside and outside of exons 5-8 in breast and other cancers (1994) (0)
Abstract 3699: Tumor budding: A predictor for metastasis in the CAM xenograft model (2019) (0)
864PLong non-coding RNAs are differentially expressed between bladder cancer subtypes (2017) (0)
Gene expression analysis of the insulin- and estrogen signalling system and their influence on clinical parameters of breast cancer patients (2008) (0)
Supplementary Material for: ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ (2016) (0)
Perforations after routine biopsy in IBD patients, their management and potential risk reductions by microscopic imaging with endocytoscopy. (2020) (0)
Abstract 2838: p53-R72P single nucleotide polymorphism is not associated with cancer risk, histopathologic features or clinical outcome in renal cell carcinoma in Caucasians (2010) (0)
Metabolic Fatty Liver Disease (2009) (0)
Incidence of carcinoma in situ (CIS) and muscle-invasive bladder cancer by gender: Analysis of 600 primary cases at initial presentation. (2010) (0)
689: Bellini duct carcinomas have a different genetic signature compared to urothelial carcinomas of the upper urinary tract (2014) (0)
Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial (2019) (0)
Abstract 1167: The expression of urokinase plasminogen activator (uPA) system genes in prostate carcinoma is related to clinicopathological parameters (2012) (0)
Assessing Disease Activity in Crohn's Disease Using Multispectral Optoacoustic Tomography (2017) (0)
[Immunotherapy in urothelial carcinoma from a pathologist's perspective]. (2017) (0)
Molecular markers (FGFR3 mutation; p53 and Ki-67 expression) and clinical outcome of radical cystectomy for bladder cancer: A multi-center, multi-laboratory study (2019) (0)
923 PLASMACYTOID UROTHELIAL CARCINOMA: RARE VARIANT OF AGGRESSIVE UROTHELIAL CARCINOMA (2010) (0)
Prognostic potential of histopathology combined with HPV status and microRNAs in penile squamous cell carcinomas (2018) (0)
ALR, a hepatotrophic protein essential for liver regeneration is overexpressed in hepatocellular carcinoma and cirrhosis (2007) (0)
Prostate Cancer Diagnosis in High Risk Patients – The Finasteride Challenge Trial (2008) (0)
Abstract 2769: Response to 5FU therapy in colorectal cancer is affected by EZH2-mediated BclX splicing (2016) (0)
Contents Vol. 19, 2001 (2002) (0)
Abstract 1164:MTUS1as a potential progression marker at chromosome 8p in bladder cancer (2012) (0)
MP-12.04 (2006) (0)
599 REGULATORY MECHANISMS OF E-CADHERIN LOSS IN PLASMACYTOID UROTHELIAL CARCINOMA (2011) (0)
294 Hormonal receptor and Her2 status correlates independently of gender with staging and grading in non muscle-invasive urothelial bladder carcinoma (2016) (0)
[Minutes of the meeting of the Working Group on Uropathology]. (2013) (0)
758P Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC) (2020) (0)
24PPhosphoproteomic assessment of HER2 signaling pathway in HER2 non-amplified patients of the GeparQuattro and GeparQuinto trials (2015) (0)
Abstract 3485: Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes (2018) (0)
[Liver histology in hepatitis C: correlation with different biochemical and virological parameters]. (2000) (0)
[Meeting report of the Working Group on Uropathology]. (2011) (0)
Breast MRI at Very Short TE (minTE): Image Analysis of minTE Sequences on Non-Fat-Saturated, Subtracted T1-Weighted Images (2017) (0)
Prospective randomized, multi-center phase 3 study: pre-operative chemoradiotherapy followed by cystectomy vs cystectomy in localized agvanced vesical cancer: AUO/ARO-08 Study (2010) (0)
Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells (2019) (0)
Serum markers for hepatic fibrosis in chronic hepatitis C (2000) (0)
Tu1878 Inflammatory Bowel Disease Patients Failing Anti-TNF Therapy Show Activation of the Th9/TH17 Pathway (2012) (0)
313 Expression pattern of the novel melanoma inhibitory activity gene 2 (MIA2) in healthy and diseased human liver (2004) (0)
Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer (2020) (0)
[Correlation of FGFR3 mutations and chromosomal alterations in bladder cancer]. (2006) (0)
unter-Breast Cancer Risk – Genes, Environment and Clinics Gene, Umwelt und Klinik (2011) (0)
Contents Vol. 97, 2016 (2016) (0)
19. Bildgebende diagnostische Technik (2017) (0)
Role of the STK 15 Phe 31 Ile polymorphism in renal cell carcinoma (0)
Pathologie der Mamma (2017) (0)
Erratum to: DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions (2016) (0)
[Diagnostic and predictive molecular pathology of head and neck neoplasms]. (2018) (0)
123 ASSESSMENT OF MOLECULAR DIFFERENCES BETWEEN EARLY AND LATELY DEVELOPED RENAL CELL CARCINOMA (2011) (0)
Panel Sequencing in Uterine Leiomyomas identifies Missense Mutations associated with immunohistochemical Fumarate Hydratase (FH)-Loss (2019) (0)
Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (2020) (0)
1020: Molecular Characterization of Carcinomas of the Upper Urinary Tract with Mutator Phenotype: Is there a Distinct Pathway of Carcinogenesis? (2004) (0)
TITLE: INTEGRATED ANALYSIS OF PTEN AND p4EBP1 PROTEIN EXPRESSION AS PREDICTORs FOR pCR IN HER2 POSITIVE BREAST CANCER (2015) (0)
550 PERINODAL LYMPHOVASCULAR INVASION IS A STRONGE PREDICTOR FOR CANCER-SPECIFIC MORTALITY IN LYMPH NODE-POSITIVE UROTHELIAL CARCINOMA OF THE BLADDER (2012) (0)
Original Article Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk (2013) (0)
[Minutes of the meeting of the Working Group on Uropathology: on the occassion of the 93rd Annual Conference of the German Society of Pathology in Freiburg]. (2009) (0)
Role of Surgical Pathologist for Detection of Predictive Immuno-oncological Factors in Breast Cancer (2022) (0)
Abstract 476: Differential prognostic value of MYC immunohistochemistry in papillary RCC subtypes (2016) (0)
[The conference chairman's opening speech at the 101st German Society for Pathology annual meeting]. (2017) (0)
Original Article Long term follow up of through-the-scope balloon dilation as compared to strictureplasty and bowel resection of intestinal strictures in crohn's disease (2014) (0)
[Histological subtypes of renal cell carcinoma : Overview and new developments]. (2021) (0)
Tu1937 MAGNIFICATION ENDOSCOPY WITH OPTICAL CHROMOENDOSCOPY FOR THE IN VIVO ASSESSMENT OF HISTOLOGIC INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2019) (0)
Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors. Commentary : Lessons from urothelium and skin (2007) (0)
Abstract 5156: Establishment of a FISH based analysis for individual risk assessment of ccRCC patients on tissue microarrays (2015) (0)
[The German Renal Cell Tumor Network]. (2008) (0)
Abstract 4037: Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC) (2019) (0)
GENETIC PROFILING OF UROTHELIAL CARCINOMAS OF THE UPPER URINARY TRACT (2006) (0)
A steatotic environment promotes the progression of hepatocellular carcinoma via direct and indirect mechanisms (2015) (0)
Original Article Expression of fatty acid synthase in nonalcoholic fatty liver disease (2010) (0)
Relevance of HPV-status and histopathology for prognosis and miRNA expression in patients with penile carcinoma (2018) (0)
Abstract 2194: p21Waf1/Cip1dependent chromatin modifications in colorectal tumor cells (2015) (0)
Erratum to: Diagnostic challenge of atypical colorectal metastasis to the renal pelvis (2010) (0)
1572: MCM2 Predicts Recurrence Hazard in Non-Invasive Bladder Cancer More Accurately than CK20, Kl67 and Histological Grade (2007) (0)
Stiff Young Woman (2015) (0)
279: "Natural Treated History" in Young Adults with Transitional Cell Carcinoma of the Bladder (TCCB) (2004) (0)
Prospective evaluation of predictive and prognostic molecular markers in colorectal carcinomas. (2010) (0)
P070 Activation of the Th9/Th17 pathway in inflammatory bowel disease patients failing anti-TNF therapy (2012) (0)
Bericht zur Late-Breaking Session Pathologie und COVID-19 (2020) (0)
EP-1330: Individual risk for biochemical recurrence in T2/T3a R1 prostate cancer - a multicenter study (2014) (0)
Accuracy of vulvoscopic findings in detecting early vulvar neoplasia (2020) (0)
[Morphology of non cutaneous head and neck squamous cell carcinoma]. (2018) (0)
607: Different Genetic Patterns of Bladder Cancer in Young Patients? (2006) (0)
Abstract A15: Uninflamed immunologic microenvironment of muscle-invasive bladder cancer associates with activating FGFR3 gene alterations (2020) (0)
Abstract 784: Plasmacytoid urothelial carcinoma: Molecular and histopathological characterization of a rare variant of bladder cancer (2010) (0)
' s response to reviews Title : Prognostic relevance of Wnt-inhibitory factor-1 ( WIF 1 ) and Dickkopf-3 ( DKK 3 ) promoter methylation in human breast cancer (2009) (0)
Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression (2023) (0)
Subject Index Vol. 19, 2001 (2002) (0)
Prospective evaluation of predictive and prognostic molecular markers in colorectal carcinomas (2011) (0)
868 Histologic subtypes of bladder cancer influence overall survival of patients treated by radical cystectomy and adjuvant cisplatin-based chemotherapy (2012) (0)
Contents Vol. 114, 2006 (2006) (0)
774: COX2 Expression is Frequent in Advanced Urinary Bladder Cancer with Features of Genomic Instability (2005) (0)
Endocr Relat Cancer published (2015) (0)
747 Identification of specific methylation-based biomarkers for the assessment of the metastatic risk of muscle invasive bladder cancer (2015) (0)
380 - IL-23 Confers Molecular Resistance to Anti-TNF Therapy in Crohn's Disease Patients (2018) (0)
Low CD3+ cell count in tumour stroma is associated with worse cancer-specific survival of stage T1G3 urothelial bladder cancer (2017) (0)
Immune monitoring in patients with colorectal cancer stage II (2015) (0)
Imaging , Diagnosis , Prognosis KPNA 2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy (2011) (0)
Immunomonitoring in patients with stage II and III colon cancer. (2017) (0)
Paul Hermanek (2020) (0)
Different Effects of the Functional MCP–1 Polymorphism (A–2518G) on Hepatic Fibrosis and Hepatocancerogenesis (2005) (0)
Long non-coding RNAs as markers for prognosis and drug target gene expression in muscle-invasive bladder cancer (2018) (0)
1767: Classification of Renal Cell Carcinomas by Multi-Color Fish (2004) (0)
[Hereditary renal cell carcinomas]. (2010) (0)
MP58-03 IDENTIFICATION OF SPECIFIC METHYLATION-BASED BIOMARKERS FOR THE ASSESSMENT OF THE METASTATIC RISK OF MUSCLE INVASIVE BLADDER CANCER (2015) (0)
[Report of the working group on uropathology of the German Society of Pathology 2015]. (2015) (0)
MP61-10 PROGNOSTIC ROLE OF FGFR ALTERATIONS AND FGFR MRNA EXPRESSION IN METASTATIC UROTHELIAL CANCER TREATED WITH ANTI-PD(L1) INHIBITORS IN FIRST AN SECOND LINE SETTING (2020) (0)
Abstract 3649: DAPK-dependent apoptosis induction after treatment of colorectal tumor cells with the histone deacetylase inhibitor panobinostat (LBH589) (2010) (0)
Kidney Cancer, Abstract 65–72, Posters (2003) (0)
[Mesenchymal tumors of the urinary bladder]. (2016) (0)
Regulation and Function of the atypical cadherin FAT1 in hepatocellular carcinoma (2013) (0)
[SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts]. (2021) (0)
TUMORIGENESIS AND NEOPLASTIC PROGRESSION Death-Associated Protein Kinase Controls STAT 3 Activity in Intestinal Epithelial Cells (2013) (0)
Utility value of the S3-score in metastatic and non-metastatic clear cell renal cell carcinoma for a molecular prediction of clinical outcome (2018) (0)
824 Clinical, histopathological and molecular characterization of early onset bladder cancer (2004) (0)
Mammographic Density and Dense Area as Risk Factors for Breast Cancer (2012) (0)
Abstract LB-218: S100A9 is a novel biomarker for poor survival of breast cancer patients (2010) (0)
Abstract 4687: COL10A1, MMP-11 and ABHD2 expression in colorectal carcinoma primary tumors indicates metastatic disease. (2013) (0)
900 Sub-stage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer (2014) (0)
The novel gene MIA2 promotes progression of hepatocellular carcinoma (2006) (0)
DICER1-Mutated Botryoid Fibroepithelial Polyp of the Parotid Duct: Report of the First Case (2021) (0)
Pigmented villonodular synovitis (PVNS)- like changes in periprothetic interface membranes (2014) (0)
732 CHARACTERIZATION OF MOLECULAR DIFFERENCES BETWEEN RENAL CELL CARCINOMA IN YOUNG ADULT AND OLD PATIENTS (2011) (0)
Dark field imaging in a series of surgery specimens of breast cancer patients (2015) (0)
Histopathology and Molecular Pathology of Bladder Cancer (2011) (0)
[Meeting report of the working group on Uropathology]. (2012) (0)
MP28-06 METASTATIC RISK STRATIFICATION OF CLEAR CELL RENAL CELL CARCINOMA PATIENTS BASED ON A GENOMIC SCORE (2018) (0)
Molecular Pathology, Abstract 1–24, Study Group (2003) (0)
Abstract LB-65: A gene expression predictor of pathological node stage of urothelial bladder cancer (2010) (0)
Development of a Superior Method for the Reliable Expansion of Tumor-Infiltrating Natural Killer cells from Rare Human Malignancies for the Purposes of ex vivo Immunophenotyping and Immunotherapy (2021) (0)
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening (2013) (0)
Smoking status and PD-L1 mRNA-expression as a predictor of response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer. (2020) (0)
286 Collecting duct carcinomas have a different genetic signature compared to upper urinary tract urothelial carcinomas (2014) (0)
224 Genetic alterations in specific chromosomal regions indicate metastatic potential in ccRCC patients (2016) (0)
53 Correlation of genomic alterations and HPV infection in penile carcinoma (2014) (0)
Abstract 1853: Piwi-like 1 and -4 gene transcript levels are associated with clinicopathological parameters in renal cell carcinomas (2014) (0)
The extracellular matrix protein ITIH5 is a novel prognostic tissue marker in invasive breast cancer and its expression is regulated by promoter hypermethylation (2007) (0)
MP23-17 BELLINI DUCT CARCINOMAS HAVE A DIFFERENT GENETIC SIGNATURE COMPARED TO UROTHELIAL CARCINOMAS OF THE UPPER URINARY TRACT (2014) (0)
[Sebaceous breast carcinoma: report of a rare histological special subtype]. (2014) (0)
HGF mediated downregulation of the novel gene MIA2 promotes progression of hepatocellular carcinoma (2007) (0)
Multiomic approach to determine prognosis for patients with HER2-positive breast cancer (2016) (0)
Abstract 563: Evaluation of EGFR mutation analysis performed by Sanger sequencing versus real-time PCR (EGFR RGQ PCR Kit) (2015) (0)
MP65-13 SUB-STAGE ACCORDING TO MICRO AND EXTENSIVE LAMINA PROPRIA INVASION IMPROVES PROGNOSTICS IN T1 BLADDER CANCER (2014) (0)
Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders (2020) (0)
Abstract P2-09-02: Blinded molecular subtyping analysis from RNA-Seq of FFPE samples in the GeparQuinto trial reveals predictive value of VEGFA metagene for bevacizumab treatment (2018) (0)
Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder. (2011) (0)
The role of reference pathology to assess MRI-TRUS fusion prostate biopsies in a tertiary referral center. (2018) (0)
Immunological microenvironment of FGFR3 altered muscle-invasive bladder cancer (2019) (0)
679Rapid identification of renal cell carcinomas by multi-colour fish (2005) (0)
1435 POSTER Prostate Cancer Prognosis by Real-time PCR Analysis of PITX2 Methylation (2011) (0)
Abstract 1840: P53 codon 72 SNP (R72P) and prostate cancer risk (2010) (0)
Strong COX-2 overexpression is frequent in breast cancers with HER2 amplification and p53 mutations and associated with poor clinical outcome (2004) (0)
Abstract 4182: Tissue microarray validation of Cathepsin E, Maspin, PLK-1, Survivin and TRIM29 expression as prognostic protein markers for stage pTa and pT1 urothelial carcinoma (2011) (0)
Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma (2020) (0)
722 SPECIFIC PROTEIN PATTERNS CHARACTERIZE METASTATIC POTENTIAL IN ADVANCED BLADDER CANCER (2010) (0)
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy (2013) (0)
Abstract 3862: Functional characterization of sFRP1 expression loss in human papillary bladder cancer (2011) (0)
[Report of the meeting of the working group on uropathology 2014]. (2014) (0)
Low frequency of chromosomal alterations in CGH analysis in low-risk papillary bladder tumors with FGFR3 mutations (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Arndt Hartmann?

Arndt Hartmann is affiliated with the following schools:

Technical University of Munich
Karolinska Institute
University of Zurich
University of Southampton
Saarland University
Humboldt University of Berlin
University of Erlangen–Nuremberg
ETH Zurich
University of Regensburg
Hannover Medical School
University of Basel

Arndt Hartmann's Academic­Influence.com Rankings

Why Is Arndt Hartmann Influential?

Arndt Hartmann's Published Works

Published Works

What Schools Are Affiliated With Arndt Hartmann?

Arndt Hartmann's AcademicInfluence.com Rankings